# Adamas Trust, Inc.: financial statements, quarterly

ADAM · Nasdaq · CIK 1273685 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/adam.md) · [Financials](/companies/adam/financials.md) · [Filings](/companies/adam/filings.md) · [Insiders](/companies/adam/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/adam/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(93.9)](/filings/0001273685-24-000081.md) | [32.9 d](/filings/0001273685-26-000029.md) | [(80.2)](/filings/0001273685-25-000047.md) | [(23.7)](/filings/0001273685-25-000072.md) | [42.8](/filings/0001273685-25-000088.md) | [(31.8) d](/filings/0001273685-26-000029.md) | [37.7](/filings/0001273685-26-000045.md) | [4.3](/filings/0001273685-26-000069.md) | [39.5](/filings/0001273685-25-000088.md) | [56.3 d](/filings/0001273685-26-000029.md) | [86.7](/filings/0001273685-26-000045.md) | [53.1](/filings/0001273685-26-000069.md) |
| Interest expense | $m | [48.4](/filings/0001273685-23-000103.md) | [62.0 d](/filings/0001273685-24-000033.md) | [66.0](/filings/0001273685-24-000053.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.1)](/filings/0001273685-24-000081.md) | [0.1 d](/filings/0001273685-26-000029.md) | [(0.1)](/filings/0001273685-25-000047.md) | [0.3](/filings/0001273685-25-000072.md) | [2.3](/filings/0001273685-25-000088.md) | [(1.5) d](/filings/0001273685-26-000029.md) | [0.6](/filings/0001273685-26-000045.md) | [(0.2)](/filings/0001273685-26-000069.md) | [(0.3)](/filings/0001273685-25-000088.md) | [(0.0) d](/filings/0001273685-26-000029.md) | [0.2](/filings/0001273685-26-000045.md) | [0.0](/filings/0001273685-26-000069.md) |
| Net income | $m | [(84.5)](/filings/0001273685-24-000081.md) | [41.9 d](/filings/0001273685-26-000029.md) | [(57.9)](/filings/0001273685-25-000047.md) | [(15.6)](/filings/0001273685-25-000072.md) | [42.8](/filings/0001273685-25-000088.md) | [(31.4) d](/filings/0001273685-26-000029.md) | [42.2](/filings/0001273685-26-000045.md) | [8.5](/filings/0001273685-26-000069.md) | [44.8](/filings/0001273685-25-000088.md) | [53.5 d](/filings/0001273685-26-000029.md) | [48.6](/filings/0001273685-26-000045.md) | [55.2](/filings/0001273685-26-000069.md) |
| Diluted EPS | $ per share | [(1.04)](/filings/0001273685-24-000081.md) | not reported | [(0.75)](/filings/0001273685-25-000047.md) | [(0.29)](/filings/0001273685-25-000072.md) | [0.36](/filings/0001273685-25-000088.md) | not reported | [0.33](/filings/0001273685-26-000045.md) | [(0.04)](/filings/0001273685-26-000069.md) | [0.36](/filings/0001273685-25-000088.md) | not reported | [0.40](/filings/0001273685-26-000045.md) | [0.47](/filings/0001273685-26-000069.md) |
| Basic EPS | $ per share | [(1.04)](/filings/0001273685-24-000081.md) | not reported | [(0.75)](/filings/0001273685-25-000047.md) | [(0.29)](/filings/0001273685-25-000072.md) | [0.36](/filings/0001273685-25-000088.md) | not reported | [0.33](/filings/0001273685-26-000045.md) | [(0.04)](/filings/0001273685-26-000069.md) | [0.36](/filings/0001273685-25-000088.md) | not reported | [0.41](/filings/0001273685-26-000045.md) | [0.48](/filings/0001273685-26-000069.md) |

- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001273685-24-000081.md) | [0.2](/filings/0001273685-26-000029.md) | [0.2](/filings/0001273685-25-000047.md) | [0.2](/filings/0001273685-25-000072.md) | [0.2](/filings/0001273685-25-000088.md) | [0.2](/filings/0001273685-26-000029.md) | [0.2](/filings/0001273685-26-000045.md) | [0.2](/filings/0001273685-26-000069.md) | [0.2](/filings/0001273685-25-000088.md) | [0.2](/filings/0001273685-26-000069.md) | [0.2](/filings/0001273685-26-000045.md) | [0.2](/filings/0001273685-26-000069.md) |
| Total assets | $bn | [6.9](/filings/0001273685-23-000103.md) | [7.4](/filings/0001273685-25-000028.md) | [7.4](/filings/0001273685-24-000053.md) | [8.2](/filings/0001273685-24-000063.md) | [8.9](/filings/0001273685-24-000081.md) | [9.2](/filings/0001273685-26-000029.md) | [10.0](/filings/0001273685-25-000047.md) | [10.6](/filings/0001273685-25-000072.md) | [12.4](/filings/0001273685-25-000088.md) | [12.6](/filings/0001273685-26-000069.md) | [12.8](/filings/0001273685-26-000045.md) | [13.0](/filings/0001273685-26-000069.md) |
| Total liabilities | $bn | [5.3](/filings/0001273685-23-000103.md) | [5.8](/filings/0001273685-25-000028.md) | [5.9](/filings/0001273685-24-000053.md) | [6.8](/filings/0001273685-24-000063.md) | [7.4](/filings/0001273685-24-000081.md) | [7.8](/filings/0001273685-26-000029.md) | [8.6](/filings/0001273685-25-000047.md) | [9.2](/filings/0001273685-25-000072.md) | [11.0](/filings/0001273685-25-000088.md) | [11.2](/filings/0001273685-26-000069.md) | [11.3](/filings/0001273685-26-000045.md) | [11.5](/filings/0001273685-26-000069.md) |
| Long-term debt | $bn | [0.5](/filings/0001273685-23-000103.md) | [0.9](/filings/0001273685-24-000033.md) | [1.0](/filings/0001273685-24-000053.md) | [0.8](/filings/0001273685-24-000063.md) | [0.7](/filings/0001273685-24-000081.md) | [0.6](/filings/0001273685-25-000028.md) | [0.7](/filings/0001273685-25-000047.md) | [0.7](/filings/0001273685-25-000072.md) | [0.8](/filings/0001273685-25-000088.md) | [0.7](/filings/0001273685-26-000029.md) | [0.7](/filings/0001273685-26-000045.md) | [0.7](/filings/0001273685-26-000069.md) |
| Shareholders' equity | $bn | [1.6](/filings/0001273685-23-000103.md) | [1.6](/filings/0001273685-25-000028.md) | [1.5](/filings/0001273685-24-000053.md) | [1.4](/filings/0001273685-24-000063.md) | [1.4](/filings/0001273685-24-000081.md) | [1.4](/filings/0001273685-26-000029.md) | [1.4](/filings/0001273685-25-000047.md) | [1.4](/filings/0001273685-25-000072.md) | [1.4](/filings/0001273685-25-000088.md) | [1.4](/filings/0001273685-26-000069.md) | [1.5](/filings/0001273685-26-000045.md) | [1.5](/filings/0001273685-26-000069.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [28.4 d](/filings/0001273685-24-000081.md) | [13.1 d](/filings/0001273685-26-000029.md) | [(13.1)](/filings/0001273685-25-000047.md) | [(1.0) d](/filings/0001273685-25-000072.md) | [(0.9) d](/filings/0001273685-25-000088.md) | [29.1 d](/filings/0001273685-26-000029.md) | [25.8](/filings/0001273685-26-000045.md) | [39.2 d](/filings/0001273685-26-000069.md) | [6.9 d](/filings/0001273685-25-000088.md) | [62.1 d](/filings/0001273685-26-000029.md) | [(16.7)](/filings/0001273685-26-000045.md) | [106 d](/filings/0001273685-26-000069.md) |
| Capital expenditure | $m | [11.8 d](/filings/0001273685-24-000081.md) | [5.6 d](/filings/0001273685-26-000029.md) | [6.0](/filings/0001273685-24-000053.md) | [7.6 d](/filings/0001273685-24-000063.md) | [7.6 d](/filings/0001273685-24-000081.md) | [3.5 d](/filings/0001273685-26-000029.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [27.4 d](/filings/0001273685-24-000081.md) | [27.2 d](/filings/0001273685-26-000029.md) | [20.5](/filings/0001273685-25-000047.md) | [18.2 d](/filings/0001273685-25-000072.md) | [18.1 d](/filings/0001273685-25-000088.md) | [18.1 d](/filings/0001273685-26-000029.md) | [18.5](/filings/0001273685-26-000045.md) | [18.2 d](/filings/0001273685-26-000069.md) | [18.1 d](/filings/0001273685-25-000088.md) | [20.8 d](/filings/0001273685-26-000029.md) | [21.4](/filings/0001273685-26-000045.md) | [20.8 d](/filings/0001273685-26-000069.md) |
| Share repurchases | $m | [5.0 d](/filings/0001273685-24-000081.md) | [0.0 d](/filings/0001273685-26-000029.md) | [0.0](/filings/0001273685-24-000053.md) | [3.5 d](/filings/0001273685-25-000072.md) | [0.0 d](/filings/0001273685-25-000088.md) | [0.0 d](/filings/0001273685-26-000029.md) | [0.0](/filings/0001273685-26-000045.md) | [1.5 d](/filings/0001273685-26-000069.md) | [0.0 d](/filings/0001273685-25-000088.md) | [0.0 d](/filings/0001273685-26-000029.md) | [5.0](/filings/0001273685-26-000045.md) | [0.0 d](/filings/0001273685-26-000069.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [94.3](/filings/0001273685-23-000103.md) | [91.7](/filings/0001273685-24-000053.md) | [91.2](/filings/0001273685-24-000063.md) | [91.0](/filings/0001273685-24-000081.md) | [91.1](/filings/0001273685-25-000047.md) | [91.0](/filings/0001273685-25-000072.md) | [90.6](/filings/0001273685-25-000088.md) | [91.1](/filings/0001273685-26-000045.md) | [90.3](/filings/0001273685-26-000069.md) | [91.6](/filings/0001273685-25-000088.md) | [92.1](/filings/0001273685-26-000045.md) | [92.3](/filings/0001273685-26-000069.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 89,879,786 at 2026-07-24, from the cover of the [10-Q filed 2026-07-31](/filings/0001273685-26-000069.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.